Published in Food and Drug Law Weekly, March 30th, 2007
Revenue was $4.4 million for the year ended December 31, 2006, compared to $3.8 million for the year ended December 31, 2005. The increase was mainly due to increased license fee revenue from the Company's...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Food and Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.